A myriad of tumor cells such as prostate cancer cells, express active Akt because of the loss of lipid phosphatase PTEN gene, a prominent inhibitor of phosphatidylinositol 3-kinase (PI3K) pathway (Figure 4). The gene discussed is AKT1; the disease is prostate cancer.